Show simple item record

dc.creatorRocha, Darío
dc.creatorGarcía, Iris A.
dc.creatorMontoro, Aldana González
dc.creatorLlera, Andrea Sabina
dc.creatorPrato, Laura
dc.creatorGirotti, María Romina
dc.creatorSoria, Gastón
dc.creatorFernández, Elmer Andrés
dc.date2020-12-31
dc.date.accessioned2023-04-10T17:41:00Z
dc.date.available2023-04-10T17:41:00Z
dc.identifierhttp://pa.bibdigital.ucc.edu.ar/3389/1/A_Rocha_Garcia_Montoro.pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12032/85841
dc.descriptionStudying tissue-independent components of cancer and defining pan-cancer subtypes could be addressed using tissue-specific molecular signatures if classification errors are controlled. Since PAM50 is a well-known, United States Food and Drug Administration (FDA)-approved and commercially available breast cancer signature, we applied it with uncertainty assessment to classify tumor samples from over 33 cancer types, discarded unassigned samples, and studied the emerging tumor-agnostic molecular patterns. The percentage of unassigned samples ranged between 55.5% and 86.9% in non-breast tissues, and gene set analysis suggested that the remaining samples could be grouped into two classes (named C1 and C2) regardless of the tissue. The C2 class was more dedifferentiated, more proliferative, with higher centrosome amplification, and potentially more TP53 and RB1 mutations. We identified 28 gene sets and 95 genes mainly associated with cell-cycle progression, cell-cycle checkpoints, and DNA damage that were consistently exacerbated in the C2 class. In some cancer types, the C1/C2 classification was associated with survival and drug sensitivity, and modulated the prognostic meaning of the immune infiltrate. Our results suggest that PAM50 could be repurposed for a pan-cancer context when paired with uncertainty assessment, resulting in two classes with molecular, biological, and clinical implications.
dc.descriptionFil: Rocha, Darío. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina
dc.descriptionFil: García, Iris A. Universidad Católica de Córdoba. CONICET. Centro de Investigación y Desarrollo en Inmunología y Enfermedades Infecciosas; Argentina
dc.descriptionFil: García, Iris A. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina
dc.descriptionFil: Montoro, Aldana González. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina
dc.descriptionFil: Montoro, Aldana González. Universidad Nacional de Córdoba. Facultad de Matemática, Astronomía y Física; Argentina
dc.descriptionFil: Llera, Andrea. Fundación Instituto Leloir. CONICET. Laboratorio de Terapia Molecular y Celular; Argentina
dc.descriptionFil: Prato, Laura. Universidad Nacional de Villa María. Instituto Académico Pedagógico de Ciencias Básicas y Aplicadas; Argentina
dc.descriptionFil: Girotti, María R. CONICET. Instituto de Biología y Medicina Experimental. Laboratorio de Inmuno Oncología Traslacional; Argentina
dc.descriptionFil: Soria, Gastón. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina
dc.descriptionFil: Soria, Gastón. CONICET. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Agrentina
dc.descriptionFil: Fernández, Elmer A. Universidad Nacional de Córdoba. Facultad de Ciencias Exactas, Físicas y Naturales; Argentina
dc.descriptionFil: Fernández, Elmer A. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Bioquímica Clínica; Argentina
dc.formatapplication/pdf
dc.languagespa
dc.publisherMDPI
dc.relationhttp://pa.bibdigital.ucc.edu.ar/3389/
dc.relationhttps://www.mdpi.com/2073-4409/10/1/45
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.3390/cells10010045
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.sourceRocha, Darío, García, Iris A., Montoro, Aldana González, Llera, Andrea Sabina ORCID: https://orcid.org/0000-0002-0089-0061 <https://orcid.org/0000-0002-0089-0061>, Prato, Laura, Girotti, María Romina, Soria, Gastón ORCID: https://orcid.org/0000-0003-2177-5094 <https://orcid.org/0000-0003-2177-5094> and Fernández, Elmer Andrés ORCID: https://orcid.org/0000-0002-4711-8634 <https://orcid.org/0000-0002-4711-8634> (2020) Pan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature. Cells, 10 (1). pp. 1-22. ISSN 2073-4409
dc.subjectR Medicina (General)
dc.subjectRC0254 Neoplasias. Los tumores. Oncología (incluyendo cáncer)
dc.titlePan-cancer molecular patterns and biological implications associated with a tumor-specific molecular signature
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record


© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP